| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |